TrialBMC infectious diseases2014

A randomised trial to evaluate the immunogenicity, reactogenicity, and safety of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) co-administered with routine childhood vaccines in Singapore and Malaysia.

Fong Seng Lim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.